Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies

Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies
Pertussis Market
Pertussis companies are Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others.

DelveInsight’s “Pertussis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Pertussis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Pertussis market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Pertussis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Pertussis market.

 

Request for a Free Sample Report @ Pertussis Market Forecast

 

Some facts of Pertussis Market Report are:

  • According to DelveInsight, Pertussis Market to Garner Considerable Growth at 1.4% CAGR by 2030.
  • The current prophylatic Pertussis market is already quite strong with GSK and Sanofi leading the space. Pertussis market comprises of DTaP vaccines and Tdap vaccines mainly, which include approved vaccines such as Adacel, Boostrix, Pediarix, Pentacel, Vaxelis, Others [Daptacel, Infanrix, Tetraxim, Pentaxim in the US; Boostrix, Repevax/Adacel Hexaxim/Hexyon/Hexacima, Vaxelis, Infanrix Hexa, Others [Daptacel, Infanrix, Tetraxim, Pentaxim] in the EU-5 countries, and Tetrabik, Tribik/BK1301 and Quattrovac in Japan.
  • Several key pharmaceutical Pertussis companies, including Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others, are developing novel products to improve the Pertussis treatment outlook.
  • Daiichi Sankyo, Mitsubishi Tanabe Pharma Corporation, and KM Biologics supply pertussis vaccinations in Japan. Mitsubishi is now leading the Japanese vaccination market with Tetrabik.
  • Countries like France and Italy have made pertussis vaccinations mandatory, while it is recommended in the vaccination schedules of the US, UK, Germany, Spain, France, and Japan.
  • For Pertussis, DelveInsight estimates that the total vaccinated population in the 7MM and China was 65,837,354 in 2020, where the US accounted for the 20,058,055 vaccination in 2020. It is important to mention that vaccination of pregnant women against pertussis has been strongly advised, however, in majority of countries the usage of vaccines is off-label. There is a high vaccination coverage for pregnant women in the UK.

 

Pertussis Overview

Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It spreads through respiratory droplets when an infected person coughs or sneezes. Pertussis typically starts with mild cold-like symptoms such as a runny nose, low-grade fever, and cough, but progresses to severe, uncontrollable coughing fits. The characteristic “whoop” sound may follow as the infected individual gasps for air. Pertussis is particularly dangerous for infants, who may experience apnea or pauses in breathing. Vaccination with the DTaP vaccine is the most effective way to prevent pertussis. However, immunity may wane over time, leading to outbreaks among both vaccinated and unvaccinated individuals. Prompt diagnosis and treatment with antibiotics can help reduce the severity and duration of symptoms, as well as limit the spread of the disease.

 

Learn more about Pertussis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/pertussis-market

 

Pertussis Market

The Pertussis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Pertussis market trends by analyzing the impact of current Pertussis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

According to DelveInsight, the Pertussis market in 7MM is expected to witness a major change in the study period 2019-2032.

 

Pertussis Epidemiology

The Pertussis epidemiology section provides insights into the historical and current Pertussis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Pertussis market report also provides the diagnosed patient pool, trends, and assumptions. 

 

Explore more about Pertussis Epidemiology @ Pertussis Market Dynamics

 

Pertussis Drugs Uptake

This section focuses on the uptake rate of the potential Pertussis drugs recently launched in the Pertussis market or expected to be launched in 2019-2032. The analysis covers the Pertussis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Pertussis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Pertussis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

 

Pertussis Pipeline Development Activities

The Pertussis market report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Pertussis key players involved in developing targeted therapeutics.

 

Request for a sample report to understand more about the Pertussis pipeline development activities @ https://www.delveinsight.com/sample-request/pertussis-market

 

Pertussis Therapeutics Assessment

Major key companies are working proactively in the Pertussis Therapeutics market to develop novel therapies which will drive the Pertussis treatment markets in the upcoming years are Sanofi Pasteur, Mitsubishi Tanabe Pharma, GlaxoSmithKline, ILiAD Biotechnologies, Serum Institute, Bilthoven, Vakzine Projekt Management GmbH (VPM), Cansino Bio, China National Biotec Group and Beijing Institute of Biological Products, and others.

 

Learn more about the emerging Pertussis therapies & key companies @ https://www.delveinsight.com/sample-request/pertussis-market

 

Pertussis Report Key Insights

1. Pertussis Patient Population

2. Pertussis Market Size and Trends

3. Key Cross Competition in the Pertussis Market

4. Pertussis Market Dynamics (Key Drivers and Barriers)

5. Pertussis Market Opportunities

6. Pertussis Therapeutic Approaches

7. Pertussis Pipeline Analysis

8. Pertussis Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Pertussis Market

 

Table of Contents

1. Key Insights

2. Executive Summary

3. Pertussis Competitive Intelligence Analysis

4. Pertussis Market Overview at a Glance

5. Pertussis Disease Background and Overview

6. Pertussis Patient Journey

7. Pertussis Epidemiology and Patient Population

8. Pertussis Treatment Algorithm, Current Treatment, and Medical Practices

9. Pertussis Unmet Needs

10. Key Endpoints of Pertussis Treatment

11. Pertussis Marketed Products

12. Pertussis Emerging Therapies

13. Pertussis Seven Major Market Analysis

14. Attribute Analysis

15. Pertussis Market Outlook (7 major markets)

16. Pertussis Access and Reimbursement Overview

17. KOL Views on the Pertussis Market

18. Pertussis Market Drivers

19. Pertussis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting


Posted

in

by

Tags: